11.04: Structure-Based Drug Design

Lectures

Regency E-F

Wednesday, July 22




02:00 - 02:15 PM
Opening Remarks. Howard Einspahr.

02:15 - 02:40 PM 11.04.01
(W0309)
Wim G. J. Hol.
Protein Crystallography in Drug Design: Tropical Diseases and Human Topisomerase I.

02:40 - 03:05 PM 11.04.02
(W0319)
Paula M. D. Fitzgerald.
HIV Protease Inhibitors: Success Stories for Structure- Based Drug Design.

03:05 - 03:30 PM 11.04.03
(W0296)
Ming Luo.
Inhibitors of Influenza Virus Neuraminidase.

03:30 - 03:45 PM 11.04.04
(W0187)
Amy L. Swain.
Crystal Structures of An MHC Class II Molecule, DRA/DRB1*0401, in Complex with Peptidomimetic Inhibitors.
et al: David R. Bolin, Robert Crowther, Kouichi Ito, Ursula Kammlott, Gary L. Olson, Zoltan Nagy, Robert Palermo, Ramakanth Sarabu.

03:45 - 04:05 PM
Coffee Break.

04:05 - 04:30 PM 11.04.05
(W0333)
Sherin Abdel-Meguid.
Lessons Learned from a Decade of Structure- Based Drug Design.

04:30 - 04:45 PM 11.04.06
(E0022)
Jon D. Robertus.
Structure- Based Design of RIP Inhibitors Against Ricin and Shiga Toxin.
et al: Darcie Miller, Maria Svinth, Xinjian Jan, Arthur F. Monzingo.

04:45 - 05:00 PM 11.04.07
(W0340)
Corey Strickland.
Structural Studies of Farnesyl Protein Transferase.

05:00 - 05:15 PM 11.04.08
(W0068)
Jerry Alexandratos.
Structure of the Catalytic Domain of Avian Sarcoma Virus Integrase with Bound HIV-1 IN Inhibitor.
et al: Jacek Lubkowski, Fan Yang, Alexander Wlodawer, He Zhao, Terrence Burke, Nouri Neamati, Yves Pommier, George Merkel, Anna Marie Skalka.

05:15 - 05:30 PM 11.04.09
(W0157)
Ossama El-Kabbani.
Structure- Based Drug Design of Aldose and Aldehyde Reductases.
et al: Mark Von Itzstein.


Contact: aca-inquiries@hwi.buffalo.edu

Last updated: Tue Jul 14 13:32:52 EDT 1998


WG
WebGlimpse
Search Options
Search: The neighborhood of this page The full archive